These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 24686085)

  • 21. Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells.
    Bertagnolo V; Marchisio M; Brugnoli F; Bavelloni A; Boccafogli L; Colamussi ML; Capitani S
    Cell Growth Differ; 2001 Apr; 12(4):193-200. PubMed ID: 11331248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
    Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
    J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout.
    MacDonald RJ; Shrimp JH; Jiang H; Zhang L; Lin H; Yen A
    Sci Rep; 2017 Dec; 7(1):17406. PubMed ID: 29234114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells.
    Lewandowski D; Linassier C; Iochmann S; Degenne M; Domenech J; Colombat P; Binet C; Hérault O
    Br J Haematol; 2002 Aug; 118(2):535-44. PubMed ID: 12139742
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBL mutation-related patterns of phosphorylation and sensitivity to tyrosine kinase inhibitors.
    Makishima H; Sugimoto Y; Szpurka H; Clemente MJ; Ng KP; Muramatsu H; O'Keefe C; Saunthararajah Y; Maciejewski JP
    Leukemia; 2012 Jul; 26(7):1547-54. PubMed ID: 22246246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence of off-target effects of bosutinib that promote retinoic acid-induced differentiation of non-APL AML cells.
    Kazim N; Yen A
    Cell Cycle; 2021 Dec; 20(24):2638-2651. PubMed ID: 34836491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Juvenile myelomonocytic leukaemia-associated mutation in Cbl promotes resistance to apoptosis via the Lyn-PI3K/AKT pathway.
    Bunda S; Qin K; Kommaraju K; Heir P; Ohh M
    Oncogene; 2015 Feb; 34(6):789-97. PubMed ID: 24469048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CBL linker region and RING finger mutations lead to enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling via elevated levels of JAK2 and LYN.
    Javadi M; Richmond TD; Huang K; Barber DL
    J Biol Chem; 2013 Jul; 288(27):19459-70. PubMed ID: 23696637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steel factor induces tyrosine phosphorylation of CRKL and binding of CRKL to a complex containing c-kit, phosphatidylinositol 3-kinase, and p120(CBL).
    Sattler M; Salgia R; Shrikhande G; Verma S; Pisick E; Prasad KV; Griffin JD
    J Biol Chem; 1997 Apr; 272(15):10248-53. PubMed ID: 9092574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Signal transduction via the CD38/NAD+ glycohydrolase.
    Kontani K; Kukimoto I; Kanda Y; Inoue S; Kishimoto H; Hoshino S; Nishina H; Takahashi K; Hazeki O; Katada T
    Adv Exp Med Biol; 1997; 419():421-30. PubMed ID: 9193684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dasatinib (BMS-354825) inhibits Stat5 signaling associated with apoptosis in chronic myelogenous leukemia cells.
    Nam S; Williams A; Vultur A; List A; Bhalla K; Smith D; Lee FY; Jove R
    Mol Cancer Ther; 2007 Apr; 6(4):1400-5. PubMed ID: 17431118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADP-Ribosyl cyclase in rat vascular smooth muscle cells: properties and regulation.
    de Toledo FG; Cheng J; Liang M; Chini EN; Dousa TP
    Circ Res; 2000 Jun; 86(11):1153-9. PubMed ID: 10850967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD38-mediated growth suppression of B-cell progenitors requires activation of phosphatidylinositol 3-kinase and involves its association with the protein product of the c-cbl proto-oncogene.
    Kitanaka A; Ito C; Nishigaki H; Campana D
    Blood; 1996 Jul; 88(2):590-8. PubMed ID: 8695807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
    Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
    Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lyn, a tyrosine kinase closely linked to the differentiation status of primary acute myeloid leukemia blasts, associates with negative regulation of all-trans retinoic acid (ATRA) and dihydroxyvitamin D3 (VD3)-induced HL-60 cells differentiation.
    Iriyama N; Yuan B; Hatta Y; Takagi N; Takei M
    Cancer Cell Int; 2016; 16():37. PubMed ID: 27182202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
    Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
    Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib-resistant chronic myeloid leukaemia.
    Gioia R; Trégoat C; Dumas PY; Lagarde V; Prouzet-Mauléon V; Desplat V; Sirvent A; Praloran V; Lippert E; Villacreces A; Leconet W; Robert B; Vigon I; Roche S; Mahon FX; Pasquet JM
    J Pathol; 2015 Sep; 237(1):14-24. PubMed ID: 25965880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LYN-activating mutations mediate antiestrogen resistance in estrogen receptor-positive breast cancer.
    Schwarz LJ; Fox EM; Balko JM; Garrett JT; Kuba MG; Estrada MV; González-Angulo AM; Mills GB; Red-Brewer M; Mayer IA; Abramson V; Rizzo M; Kelley MC; Meszoely IM; Arteaga CL
    J Clin Invest; 2014 Dec; 124(12):5490-502. PubMed ID: 25401474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
    Konig H; Copland M; Chu S; Jove R; Holyoake TL; Bhatia R
    Cancer Res; 2008 Dec; 68(23):9624-33. PubMed ID: 19047139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.